Interview: EMA’s Peter Arlett reflects on RWE approvals, early learnings from DARWIN
Regulatory NewsJoanne S. Eglovitch
BiologicsClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchBiologicsClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development